# Manufacturing Considerations for Licensed and Investigational Cellular and Gene Therapy Products During COVID-19 Public Health Emergency:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/manufacturing-considerations-for-licensed-and-investigational-cellular-and-gene-therapy-products-during-covid-19-public-health-emergency-guidance-for-industry/20ac34c3-75bd-45e5-8338-ca633985c05c

> FDA guidance document: Manufacturing Considerations for Licensed and Investigational Cellular and Gene Therapy Products During COVID-19 Public Health Emergency:  Guidance for Industry. Issue date: January 19, 2021. Get complete insights and analysis.

---

## Details

- Title: Manufacturing Considerations for Licensed and Investigational Cellular and Gene Therapy Products During COVID-19 Public Health Emergency:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2021-01-19
- Last Changed: 2021-01-20
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2020-D-1137">FDA-2020-D-1137</a>

## Related Documents

- [Recommendations for Investigational and Licensed COVID-19 Convalescent Plasma:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/recommendations-for-investigational-and-licensed-covid-19-convalescent-plasma-guidance-for-industry/b5fc3ade-12ac-4c44-9169-ec203fa8a321)
- [Development and Licensure of Vaccines to Prevent COVID-19:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/development-and-licensure-of-vaccines-to-prevent-covid-19-guidance-for-industry/c33dc669-49bf-43f1-a92c-97b2eb6d44a5)
- [Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/recommendations-to-reduce-the-risk-of-transfusion-transmitted-malaria-guidance-for-industry/eb835388-a1e0-46db-8c55-61853bcee91b)